Trial Profile
Investigation of a selective androgen receptor modulator (SARM) RAD 140 [Radius Health] for the treatment of age-related muscle-wasting and other musculoskeletal conditions such as osteoporosis.
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 Jun 2008
Price :
$35
*
At a glance
- Drugs Vosilasarm (Primary)
- Indications Muscular atrophy; Osteoporosis
- Focus Therapeutic Use
- Sponsors Radius Health Inc.
- 17 Jun 2008 New trial record.